Back
Hewlett Packard Enterprise Vs. Monopar Therapeutics Industry Stock Comparison
Sell
36
HPE
Hewlett Packard Enterprise
Last Price:
$16.33
Seasonality Move:
0.83%
Sell
45
MNPR
Monopar Therapeutics
Last Price:
$39.96
Seasonality Move:
-24.75%
Sell
36
Hewlett Packard Enterprise (HPE)
is a Sell
Is Hewlett Packard Enterprise a Buy, Sell or Hold?
-
The current Hewlett Packard Enterprise [HPE] share price is $15.93. The Score for HPE is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
HPE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
Monopar Therapeutics (MNPR)
is a Sell
Is Monopar Therapeutics a Buy, Sell or Hold?
-
The current Monopar Therapeutics [MNPR] share price is $34.37. The Score for MNPR is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
MNPR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
HPE Stock Price Chart
What is Hewlett Packard Enterprise's stock price today?
-
The Hewlett Packard Enterprise share price today is $15.93Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HPE is experiencing slight buying pressure.
MNPR Stock Price Chart
What is Monopar Therapeutics's stock price today?
-
The Monopar Therapeutics share price today is $34.37Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MNPR is experiencing buying pressure, which is a positive indicator for future bullish movement.
HPE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.62 | Sell |
Relative Strength Index (14 RSI): | 29.36 | Sell |
Chaikin Money Flow: | 7622609 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (16.64 - 21.6) | Sell |
Bollinger Bands (100): | (19.06 - 22.88) | Sell |
MNPR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.8 | Sell |
Relative Strength Index (14 RSI): | 50.93 | Buy |
Chaikin Money Flow: | 16181 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (29.38 - 44.94) | Sell |
Bollinger Bands (100): | (16.76 - 38.26) | Buy |
HPE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 15.8 | Buy |
20-day SMA: | 18.58 | Sell |
50-day SMA: | 20.71 | Sell |
200-day SMA: | 20.25 | Sell |
8-day EMA: | 16.22 | Sell |
20-day EMA: | 17.89 | Sell |
50-day EMA: | 19.7 | Sell |
200-day EMA: | 19.89 | Sell |
MNPR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 30.92 | Buy |
20-day SMA: | 34.11 | Buy |
50-day SMA: | 35.31 | Sell |
200-day SMA: | 15.6 | Buy |
8-day EMA: | 32.1 | Buy |
20-day EMA: | 33.86 | Buy |
50-day EMA: | 33.39 | Buy |
200-day EMA: | 20.23 | Buy |
Hewlett Packard Enterprise Earnings Growth & HPE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.04 per share, an increase next quarter of $0.04 per share, a decrease this year of $0.15 per share, and an increase next year of $0.28 per share.
Monopar Therapeutics Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.50 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.70 per share, and an increase next year of $2.24 per share.
Hewlett Packard Enterprise Technical Analysis
Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Monopar Therapeutics Technical Analysis
Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
04 | 05 | 06 | 07 | 11 | 12 | 13 | 14 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |